Products from BPS Bioscience
Sun, sea, and science: BPS Bioscience from San Diego, California promotes new scientific discoveries that lead to therapies by creating innovative solutions for research. BPS is an expert in recombinant proteins and enzymes, cell lines, virus-based tools, as well as biochemical and cellular assay systems. The high-quality products and services from BPS enable researchers worldwide to advance biological discoveries in a variety of disciplines, including epigenetics, cell signaling, SARS-CoV-2, immunotherapy, CRISPR, and adoptive cell therapies.
More information at: www.bpsbioscience.com
No results were found for the filter!
Auristatin E
Item number: BPS-82272-1
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor activity, it is a synthetic analog of dolastatin 10. Auristatin E is a highly potent antimitotic agent.
| Application: | ADC payload, cytotoxic tubulin modifier, highly potent antimitotic agent |
| MW: | 732,0 D |
From 975.00€
*
MMAE
Item number: BPS-82273-1
MMAE is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug itself, instead, it is linked to a monoclonal antibody (MAB) which directs it to the cancer cells. Monomethyl auristatin E or MMAE is 100-1000 times more potent than doxorubicin. It is a very potent antimitotic agent that...
| Keywords: | Monomethyl auristatin E, |
| Application: | ADC payload, tubulin polymerization inhibitor, very potent antimitotic agent, cell division inhibitor |
| MW: | 718,0 D |
From 763.00€
*
Val-Cit-PAB-MMAE
Item number: BPS-82274-1
Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a a protease-sensitive Val-Cit dipeptide, and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells.
| Application: | ADC payload, synthetic antineoplastic agent |
| MW: | 1123,5 D |
From 1,448.00€
*
MC-Val-Cit-PAB-MMAE
Item number: BPS-82275-1
MC-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a thio reactive maleimidocaproyl (MC) group, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward...
| Application: | ADC payload, synthetic antineoplastic agent |
| MW: | 1316,7 D |
From 656.00€
*
Acid-PEG4-Val-Cit-PAB-MMAE
Item number: BPS-82276-1
Acid-PEG4-Val-Cit-PAB-MMAE is a cleavable ADC linker featuring a carboxylic acid, a hydrophilic PEG spacer, and a Val-Cit-PAB dipeptide ligated to an MMAE payload. Carboxylic acids are reactive towards amines or alcohols while the Val-Cit-PAB motif is an enzyme-cleavable linker. This linker efficiently releases the...
| Application: | ADC payload, cleavable amine-reactive ADC linker, apoptosis inducer |
| MW: | 1399,7 D |
From 943.00€
*
Azide-PEG8-Val-Cit-PAB-MMAE
Item number: BPS-82277-1
Azide-PEG8-Val-Cit-PAB-MMAE is a cleavable ADC linker which contains an azide, a PEG spacer, a Val-Cit dipeptide, a PAB group, and an MMAE warhead. The azide is free to participate in click chemistry with terminal alkynes or strained cyclooctynes such as DBCO or BCN. The Val-Cit dipeptide is cleaved by cellular...
| Application: | ADC payload, click chemistry, cleavable alkyne-reactive ADC linker, apoptosis inducer |
| MW: | 1573,0 D |
From 975.00€
*
Influenza HA H3 Peptide (307-319)
Item number: BPS-82311
The Influenza HA H3 Peptide (307-319, PKYVKQNTLKLAT) is a peptide corresponding to the Influenza A virus subtype H3N2 HA (hemagglutinin), amino acids 307-319. The peptide is widely used to stimulate human H3N2 Influenza -specific CD4+ T cells.
| Application: | Human influenza H3N2-specific CD4+ T cell stimulation |
| Origin: | strain a/northern territory/60/1968 h3n2 |
340.00€
*
Influenza HA H1 Peptide (Hawaii H1N1)
Item number: BPS-82312
The Influenza HA H1 Peptide (Hawaii H1N1, PKYVKSTKLRLAT) is a peptide from the Influenza virus subtype Hawaii H1N1 HA (hemagglutinin) H1. The peptide is used as a negative control in assays using Influenza HA H3 (307-319) peptide (BPS Bioscience #82311).
| Application: | Influenza HA H3 (307-319) peptide (BPS-82311) assay negative control |
| Origin: | a/mexico city/iner16/2009(h1n1 |
340.00€
*
Vgamma4Vdelta1 TCR NFAT-Luciferase Reporter Jurkat Cell Line
Item number: BPS-82329
The Vgamma4Vdelta1 TCR NFAT-Luciferase Reporter Jurkat Cell Line was generated from the T Cell Receptor (TCR) Knockout NFAT Luciferase Reporter Jurkat Cell Line (#78556) by overexpression of human Vgamma4Vdelta1 TCR using lentiviral transduction (with Vgamma4Vdelta1 TCR Lentivirus #78986). This cell line was...
| Keywords: | T cell receptor delta constant, |
| Application: | Vgamma4Vdelta1 TCR agonist antibody screening, Vgamma4Vdelta1 TCR evaluation positive control, optim. |
| Species reactivity: | human |
17,040.00€
*
DLL1 Lentivirus
Item number: BPS-82340
DLL1 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. These particles transduce cells with human DLL1 (delta like canonical notch ligand 1) (NM_005618.4), driven by a...
| Keywords: | Delta1, H-Delta-1, Delta-like protein 1, Drosophila Delta homolog 1, |
| Application: | Human DLL1 cell expression, cell pool/stable cell line generation, puromycin selection |
| Species reactivity: | human |
1,490.00€
*
DLL4 Lentivirus
Item number: BPS-82341
DLL4 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. These particles transduce cells with human DLL4 (delta like canonical notch ligand 4) (NM_019074.4), driven by a...
| Keywords: | DLL4, Delta4, Delta-like protein 4, Drosophila Delta homolog 4, |
| Application: | Human DLL4 cell expression, cell pool/stable cell line generation, puromycin selection |
| Species reactivity: | human |
1,490.00€
*
Transduction Control (EF1A Promoter) iPS Cell Pool
Item number: BPS-82520
The Transduction Control (EF1A Promoter) iPS Cell Pool is an iPS (induced pluripotent stem) cell pool that was generated via lentiviral transduction with Expression Negative Control Lentivirus (EF1A Promoter/Puromycin Resistance) (#82212-P). This cell pool can be used as control for Cas9 Expressing iPS Cell Pool...
| Application: | Cas9 Expressing iPS Cell Pool (BPS-78578) negative control, validation, control |
2,921.00€
*
